Ironwood Return On Assets from 2010 to 2024
| IRWD Stock | USD 8.10 0.21 2.53% |
Return On Assets | First Reported 2010-12-31 | Previous Quarter (2.13) | Current Value (2.02) | Quarterly Volatility 0.74512606 |
Check Ironwood Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ironwood main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 M, Interest Expense of 19.9 M or Total Revenue of 231.7 M, as well as many exotic indicators such as Price To Sales Ratio of 3.82, Dividend Yield of 0.0465 or Days Sales Outstanding of 142. Ironwood financial statements analysis is a perfect complement when working with Ironwood Pharmaceuticals Valuation or Volatility modules.
Ironwood | Return On Assets |
Latest Ironwood Pharmaceuticals' Return On Assets Growth Pattern
Below is the plot of the Return On Assets of Ironwood Pharmaceuticals over the last few years. It is a profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets. Ironwood Pharmaceuticals' Return On Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ironwood Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Return On Assets | 10 Years Trend |
|
Return On Assets |
| Timeline |
Ironwood Return On Assets Regression Statistics
| Arithmetic Mean | (0.49) | |
| Geometric Mean | 0.36 | |
| Coefficient Of Variation | (152.74) | |
| Mean Deviation | 0.55 | |
| Median | (0.31) | |
| Standard Deviation | 0.75 | |
| Sample Variance | 0.56 | |
| Range | 2.5965 | |
| R-Value | (0.26) | |
| Mean Square Error | 0.56 | |
| R-Squared | 0.07 | |
| Significance | 0.34 | |
| Slope | (0.04) | |
| Total Sum of Squares | 7.77 |
Ironwood Return On Assets History
About Ironwood Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Ironwood Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Ironwood Pharmaceuticals investors use historical funamental indicators, such as Ironwood Pharmaceuticals's Return On Assets, to determine how well the company is positioned to perform in the future. Although Ironwood Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Ironwood Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ironwood Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Ironwood Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Ironwood Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Assets | (2.13) | (2.02) |
Ironwood Pharmaceuticals Investors Sentiment
The influence of Ironwood Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ironwood. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ironwood Pharmaceuticals' public news can be used to forecast risks associated with an investment in Ironwood. The trend in average sentiment can be used to explain how an investor holding Ironwood can time the market purely based on public headlines and social activities around Ironwood Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ironwood Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ironwood Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ironwood Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ironwood Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ironwood Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ironwood Pharmaceuticals' short interest history, or implied volatility extrapolated from Ironwood Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Ironwood Pharmaceuticals Correlation against competitors. For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Ironwood Stock analysis
When running Ironwood Pharmaceuticals' price analysis, check to measure Ironwood Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ironwood Pharmaceuticals is operating at the current time. Most of Ironwood Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ironwood Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ironwood Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ironwood Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Ironwood Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ironwood Pharmaceuticals. If investors know Ironwood will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ironwood Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.69) | Earnings Share (6.45) | Revenue Per Share 2.848 | Quarterly Revenue Growth 0.097 | Return On Assets 0.1339 |
The market value of Ironwood Pharmaceuticals is measured differently than its book value, which is the value of Ironwood that is recorded on the company's balance sheet. Investors also form their own opinion of Ironwood Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ironwood Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ironwood Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ironwood Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ironwood Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ironwood Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ironwood Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.